Zoekresultaten - Portaal voor medische datamodellen (MDM-portaal)

Swedish Bladder Cancer Registry - Treatment of Primary Tumor

- 15-11-17 - 1 Formulier, 2 Itemgroepen, 30 Data-elementen, 2 Talen

Itemgroepen: General Information, Treatment of Primary Tumor

Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ Treatment of Primary Tumor

Bladder Cancer CALGB 90104 NCT00014534 - Chemotherapy Dose Form Bladder Cancer (CALGB 90104)

- 25-07-15 - 1 Formulier, 1 Itemgroep, 26 Data-elementen, 1 Taal

Itemgroep: Chemotherapy Dose Form

CALGB: 90104 Chemotherapy Dose Form Combination Chemotherapy in Treating Patients With Bladder Cancer NCT00014534 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1C0B11-7B76-737C-E034-0003BA12F5E7

Treatment Form Bladder Cancer CALGB 90601 NCT00942331

- 25-07-15 - 1 Formulier, 6 Itemgroepen, 46 Data-elementen, 1 Taal

Itemgroepen: Header, Clinical Data, Gemcitabine, Cisplatin, Bevacizumab/placebo, Gemcitabine/Cisplatin

CALGB 90601: Treatment Form Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer NCT00942331 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=65402ABE-C4AA-902C-E040-BB89AD435D5A

Treatment - Bladder/Urothelial Cancer - Treatment by Cycle Form - 2019329v2.31 - Bladder/Urothelial Cancer - Treatment by Cycle Form

- 08-01-15 - 1 Formulier, 5 Itemgroepen, 24 Data-elementen, 1 Taal

Itemgroepen: CRF Header, BLADDER/UROTHELIAL: FORM ADMINISTRATION, BLADDER/UROTHELIAL: TREATMENT CYCLE AND MODIFICATIONS, BLADDER/UROTHELIAL: OFF-TREATMENT, Comments

Bladder/Urothelial Cancer - Treatment by Cycle Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99CD59C5-A959-3FA4-E034-080020C9C0E0

Treatment - Bladder/Urothelial Cancer - Treatment Summary Form - 2019328v2.31 - Bladder/Urothelial Cancer - Treatment Summary Form

- 08-01-15 - 1 Formulier, 8 Itemgroepen, 45 Data-elementen, 1 Taal

Itemgroepen: CRF Header, BLADDER/UROTHELIAL: FORM ADMINISTRATION, BLADDER/UROTHELIAL: TREATMENT - CHEMOTHERAPY, BLADDER/UROTHELIAL: TREATMENT SCHEDULE - RADIATION THERAPY, BLADDER/UROTHELIAL: TREATMENT SCHEDULE - SURGERY, BLADDER/UROTHELIAL: OFF-TREATMENT & MODIFICATIONS, BLADDER/UROTHELIAL: TREATMENT SCHEDULE - NON-PROTOCOL THERAPY, Comments

Bladder/Urothelial Cancer - Treatment Summary Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99CD59C5-A957-3FA4-E034-080020C9C0E0

Bladder Cancer NCT00445601 Treatment - S0337 Treatment Summary Form - 2389127v1.0 - S0337 Treatment Summary Form

- 09-01-15 - 1 Formulier, 3 Itemgroepen, 17 Data-elementen, 1 Taal

Itemgroepen: Header, Treatment, Comments

S0337 Treatment Summary Form Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FE2614FE-6335-4C27-E034-0003BA3F9857

Bladder Cancer NCT00014534 Treatment - CALGB: 90104 Treatment and Follow-up Form - 2169531v3.0 - CALGB: 90104 Treatment and Follow-up Form

- 09-01-15 - 1 Formulier, 1 Itemgroep, 61 Data-elementen, 1 Taal

Itemgroep: CCRR MODULE

CALGB: 90104 Treatment and Follow-up Form Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B6072-F2CE-7116-E034-0003BA12F5E7

Bladder Cancer NCT00014534 Treatment - NCI Cooperative Group Treatment Summary Form (CALGB-90104) - 2055978v3.0 - NCI Cooperative Group Treatment Summary Form (CALGB-90104)

- 08-01-15 - 1 Formulier, 5 Itemgroepen, 21 Data-elementen, 1 Taal

Itemgroepen: MSKCC 00-138; CALGB-90104; ECOG, Form Administration, Treatment Schedule - Chemotherapy, Off-Treatment and Modifications, CCRR MODULE

NCI Cooperative Group Treatment Summary Form (CALGB-90104) Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A9C02140-B193-2659-E034-0003BA12F5E7

Bladder Cancer NCT00014534 Treatment - NCI Cooperative Group Treatment by Cycle Form-CALGB-90104 - 2056083v3.0 - NCI Cooperative Group Treatment by Cycle Form-CALGB-90104

- 28-11-14 - 1 Formulier, 4 Itemgroepen, 23 Data-elementen, 1 Taal

Itemgroepen: MSKCC 00-138; CALGB-90104; ECOG, Form Administration, Treatment Cycles, CCRR MODULE

NCI Cooperative Group Treatment by Cycle Form-CALGB-90104 Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A9C01F91-F376-264F-E034-0003BA12F5E7

Bladder Cancer NCT01224665 Treatment - S1011 Intra-Op Surgical Assessment Form Standard Versus Extended LND (#10689) - 3153877v1.0 - S1011 Intra-Op Surgical Assessment Form Standard Versus Extended LND (#10689)

- 09-01-15 - 1 Formulier, 7 Itemgroepen, 43 Data-elementen, 1 Taal

Itemgroepen: Header Module, INTRA-OPERATIVE EXTENT-OF-DISEASE ASSESSMENT, SURGICAL ASSESSMENT OF NODAL DISSECTION, DESCRIPTION OF HOW NODAL PACKETS WERE SUBMITTED TO YOUR PATHOLOGIST, RECONSTRUCTION, OPERATIVE INFORMATION, Comments

S1011 Intra-Op Surgical Assessment Form Standard Versus Extended LND (#10689) Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=940453E3-434E-BBC7-E040-BB89AD431F9F

Bladder Cancer NCT01224665 Treatment - S1011 Surgeon's 90-Day Assessment Form Standard Versus Extended LND (#5223) - 3153915v1.0 - S1011 Surgeon's 90-Day Assessment Form Standard Versus Extended LND (#5223)

- 09-01-15 - 1 Formulier, 4 Itemgroepen, 25 Data-elementen, 1 Taal

Itemgroepen: Header Module, SURGICAL COMPLICATIONS, ADJUVANT TREATMENT RELATED TO THIS BLADDER CANCER, Comments

S1011 Surgeon's 90-Day Assessment Form Standard Versus Extended LND (#5223) Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=940453E3-43A8-BBC7-E040-BB89AD431F9F

ICHOM Localized Prostate Cancer - Clinical Form within 6 months after treatment initiation

- 20-09-21 - 1 Formulier, 3 Itemgroepen, 48 Data-elementen, 1 Taal

Itemgroepen: Patient ID, Treatment Variables, Acute Complications of Treatment

LOCALIZED PROSTATE CANCER DATA COLLECTION Version 2.0.5 Revised: April 7th , 2017 www.ichom.org Notice: This work was conducted using resources from ICHOM, the International Consortium for Health Outcomes Measurement (www.ICHOM.org). The content is solely the responsibility of the authors and does not necessarily represent the official views of ICHOM. Conditions: Localized prostate cancer Treatment Approaches: Active Surveillance | Watchful Waiting | Radical Prostatectomy* | External Beam Radiation Therapy* | Androgen Deprivation Therapy (ADT)* | Focal Therapy* | Other* * These should also be collected as salvage treatments where necessary This ODM-file contains a Clinical Form to be used 6 months after primary treatment initiation. Surveys used: Expanded Prostate Cancer Index Composite (EPIC-26): The EPIC-26 is free for all health care organizations, and a license is not needed. The scoring guide may be found at http://www.med.umich.edu/urology/research/EPIC/EPIC-26-Scoring-1.2007.pdf ; Wei J, Dunn R, Litwin M, Sandler H, and Sanda M. "Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer", Urology. 56: 899-905, 2000. For registries choosing to implement the EPIC-CP rather than the EPIC-26, we recommend using the same variable IDs as the corresponding EPIC-26 questions. This means that only questions 2, 3, 4a, 4b, 4d, 4e, 5, 6e, 6b, 7, 8b, 9, 12, 13a, 13c, and 13d of the EPIC-26 are administered. Utilization of Sexual Medications/Devices: The Utilization of Sexual Medications/Devices is free for all health care organizations, and a license is not needed. Refer to http://dx.doi.org/10.1016/j.urology.2006.01.077 for more information European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ- PR25): The EORTC QLQ-PR25 is free for all health care organizations, but a license is needed for use. Therefore it will not be integrated in this Version of the questionnaire. For more information, please visit http://groups.eortc.be/qol/eortc-qlq-c30 . ICHOM was supported for the Localized Prostate Cancer Standard Set by the Movember Foundation. For this version of the standard set, semantic annotation with UMLS CUIs has been added.

Trefwoorden

Inhoudsopgave

Geselecteerde datamodellen